$NEUP

3 stories mentioning NEUPUpdated 51d ago

Every FINWIRES story that references NEUP, newest first.

What's the latest news on NEUP?

Sector Update: Healthcare Stocks Rise Late Afternoon

Healthcare stocks advanced late Thursday afternoon with the NYSE Healthcare Index gaining 1.2% and the State Street Health Care Select Sector SPDR ETF (XLV) rising 1.1%.The iShares Biotechnology ETF (IBB) added 1%.In corporate news, Thermo Fisher Scientific (TMO) shares jumped 8.9% after fiscal Q2 adjusted earnings and revenue topped estimates.Quest Diagnostics (DGX) shares rose 8% after Q2 adjusted earnings and revenue exceeded market consensus.Neuphoria Therapeutics (NEUP) agreed to be acquired by Scancell Holdings in an all-stock deal. Neuphoria shares jumped 15%.Agilon Health (AGL) shares fell 14% after Citigroup downgraded the stock to sell from neutral and lifted its price target to $105 from $80.

$AGL$DGX$NEUP$TMO

Sectors52d ago

Sector Update: Healthcare Stocks Rise Thursday Afternoon

Healthcare stocks were higher Thursday afternoon, with the NYSE Healthcare Index rising 0.9% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.9%.The iShares Biotechnology ETF (IBB) climbed up 1%.In corporate news, Thermo Fisher Scientific (TMO) shares jumped past 8% after it reported higher fiscal Q2 adjusted earnings and revenue.Quest Diagnostics (DGX) shares rose 6.6% after the company reported higher Q2 adjusted earnings and revenue, and raised its 2026 outlook.Neuphoria Therapeutics (NEUP) and Scancell Holdings said Thursday they have struck an all-stock merger deal in which Scancell will acquire Neuphoria. Neuphoria shares surged 20%.Westin Acquisition (WSTN) and First Choice Healthcare Solutions said they have agreed to merge to create a publicly traded healthcare and wellness company. Shares edged up 0.2%.

$DGX$NEUP$TMO$WSTN

Wire52d ago

Neuphoria Therapeutics Agrees to All-Share Takeover by Scancell

Neuphoria Therapeutics (NEUP) and Scancell Holdings said Thursday they have agreed to an all-stock merger in which Scancell will acquire Neuphoria and apply to list its shares on Nasdaq under the ticker symbol "SCLT."Scancell said it expects to secure up to $89 million in financing through a combination of equity and debt.The UK company said it has received commitments from new and existing shareholders for a $39.1 million private placement and that it plans to launch a UK placing to raise about $12 million and a retail offering to raise up to $3 million.Scancell also said it has entered into a nonbinding term sheet with certain funds and accounts managed by BlackRock (BLK) for up to $25 million in debt financing, while completion of the merger is expected to provide the combined entity with at least $10 million in additional cash from Neuphoria's cash balances.The boards of both companies unanimously approved the transaction. The merger remains subject to approval by shareholders of Neuphoria and Scancell, as well as other customary closing conditions.Price: $3.96, Change: $+0.60, Percent Change: +17.87%

$BLK$NEUP

Track with the FINWIRES app suite

FolioX

Track NEUP in your portfolio

WheelAI

Analyze NEUP options with the wheel strategy

StockInsider

See market sentiment on NEUP